We are live on ! Find out more
TECH icon

Bio-Techne

280 hedge funds and large institutions have $4.39B invested in Bio-Techne in 2017 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 119 increasing their positions, 88 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

297% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $388K

63% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 19

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

35% more repeat investments, than reductions

Existing positions increased: 119 | Existing positions reduced: 88

18% more capital invested

Capital invested by funds: $3.72B → $4.39B (+$674M)

8.49% more ownership

Funds ownership: 392.07%400.56% (+8.5%)

3% more funds holding

Funds holding: 271280 (+9)

Holders
280
Holders Change
+9
Holders Change %
+3.32%
% of All Funds
6.98%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
31
Increased
119
Reduced
88
Closed
19
Calls
$1.54M
Puts
$388K
Net Calls
+$1.15M
Net Calls Change
+$978K
Name Holding Trade Value Shares
Change
Change in
Stake
PNC Financial Services Group
76
PNC Financial Services Group
Pennsylvania
$6.5M -$152K -5,568 -2%
EAM
77
Eagle Asset Management
Florida
$5.87M +$259K +9,484 +5%
Wells Fargo
78
Wells Fargo
California
$5.83M +$380K +13,900 +8%
Ohio Public Employees Retirement System (OPERS)
79
Ohio Public Employees Retirement System (OPERS)
Ohio
$5.83M +$262K +9,580 +5%
DWT
80
Dorsey & Whitney Trust
South Dakota
$5.75M -$16.4K -600 -0.3%
Los Angeles Capital Management
81
Los Angeles Capital Management
California
$5.66M +$1.88M +68,632 +55%
William Blair & Company
82
William Blair & Company
Illinois
$5.5M +$185K +6,784 +4%
Allianz Asset Management
83
Allianz Asset Management
Germany
$5.23M -$58.5K -2,140 -1%
SRC
84
Stone Run Capital
New York
$5.04M
Credit Agricole
85
Credit Agricole
France
$4.78M +$3.59M +131,188 +416%
NC
86
Nicholas Company
Wisconsin
$4.7M
WSFS
87
Wilmington Savings Fund Society
Delaware
$4.68M -$107K -3,928 -2%
TCM
88
Tygh Capital Management
Oregon
$4.65M +$4.33M +158,300 New
Skandinaviska Enskilda Banken (SEB)
89
Skandinaviska Enskilda Banken (SEB)
Sweden
$4.58M -$907K -33,200 -18%
CS
90
Credit Suisse
Switzerland
$4.49M -$216K -7,912 -5%
FLAM
91
First Light Asset Management
Minnesota
$4.49M -$875 -32 -0%
MIP
92
Mondrian Investment Partners
United Kingdom
$4.41M -$328K -12,004 -7%
MLICM
93
Metropolitan Life Insurance Company (MetLife)
New York
$4.32M +$58.7K +2,148 +1%
SIM
94
Spark Investment Management
New York
$3.79M
Barclays
95
Barclays
United Kingdom
$3.77M -$633K -23,144 -15%
CIM
96
Confluence Investment Management
Missouri
$3.62M +$192K +7,024 +6%
Legal & General Group
97
Legal & General Group
United Kingdom
$3.58M +$679K +24,832 +26%
MOACM
98
Mutual of America Capital Management
New York
$3.54M +$116K +4,252 +4%
State of Tennessee, Department of Treasury
99
State of Tennessee, Department of Treasury
Tennessee
$3.52M
CM
100
Castleark Management
Illinois
$3.5M +$3.26M +119,280 New

TECH Hedge Fund Activity: Q2 2017 in Review

280 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2017, worth a combined $4.39B — up 18% from $3.72B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new TECH positions and 19 closed out — a net gain of 12 holders — while 119 added to existing stakes and 88 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $100M. The largest seller was Select Equity Group, cutting an estimated $45.3M.

  • 280 institutional investors held Bio-Techne (TECH) as of Q2 2017, up from 271 in Q1 2017.
  • Funds reported $4.39B of Bio-Techne stock for Q2 2017, up 18% quarter-over-quarter.
  • 31 funds opened new Bio-Techne positions in Q2 2017 and 19 closed out, a net change of +12 holders.
  • The largest Bio-Techne buyer in Q2 2017 was Janus Henderson Group, an estimated $100M added.
  • The largest Bio-Techne seller in Q2 2017 was Select Equity Group, an estimated $45.3M sold.

Based on aggregated 13F filings for Q2 2017.